398 related articles for article (PubMed ID: 29902497)
1. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; de Souza BM; Bauer AC; Crispim D
Mol Cell Endocrinol; 2018 Dec; 477():90-102. PubMed ID: 29902497
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses.
Assmann TS; Recamonde-Mendoza M; Costa AR; Puñales M; Tschiedel B; Canani LH; Bauer AC; Crispim D
Acta Diabetol; 2019 Jan; 56(1):55-65. PubMed ID: 30167868
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; De Souza BM; Crispim D
Endocr Connect; 2017 Nov; 6(8):773-790. PubMed ID: 28986402
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
5. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.
Xie Y; Jia Y; Cuihua X; Hu F; Xue M; Xue Y
J Diabetes Res; 2017; 2017():6978984. PubMed ID: 29038788
[TBL] [Abstract][Full Text] [Related]
6. Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease.
Zhao Y; Shen A; Guo F; Song Y; Jing N; Ding X; Pan M; Zhang H; Wang J; Wu L; Ma X; Feng L; Qin G
Front Endocrinol (Lausanne); 2020; 11():590. PubMed ID: 32982978
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
8. Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level.
Zhang L; Li R; He J; Yang Q; Wu Y; Huang J; Wu B
Methods; 2017 Jul; 124():46-56. PubMed ID: 28577935
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression Profiling in Diabetic Kidney Disease.
Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Morishita Y
Transl Res; 2021 Nov; 237():31-52. PubMed ID: 34102327
[TBL] [Abstract][Full Text] [Related]
11. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
Han LL; Wang SH; Yao MY; Zhou H
World J Diabetes; 2024 Jan; 15(1):92-104. PubMed ID: 38313849
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease.
Zang J; Maxwell AP; Simpson DA; McKay GJ
Sci Rep; 2019 Jul; 9(1):10900. PubMed ID: 31358876
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review and Bioinformatic Analysis of microRNA Expression in Autism Spectrum Disorder Identifies Pathways Associated With Cancer, Metabolism, Cell Signaling, and Cell Adhesion.
Huang ZX; Chen Y; Guo HR; Chen GF
Front Psychiatry; 2021; 12():630876. PubMed ID: 34744804
[No Abstract] [Full Text] [Related]
14. MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis.
Assmann TS; Recamonde-Mendoza M; Puñales M; Tschiedel B; Canani LH; Crispim D
Diabetes Res Clin Pract; 2018 Jul; 141():35-46. PubMed ID: 29679626
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.
Cui C; Cui Y; Fu Y; Ma S; Zhang S
Mol Med Rep; 2018 Feb; 17(2):2161-2168. PubMed ID: 29207157
[TBL] [Abstract][Full Text] [Related]
16. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.
Beltrami C; Simpson K; Jesky M; Wonnacott A; Carrington C; Holmans P; Newbury L; Jenkins R; Ashdown T; Dayan C; Satchell S; Corish P; Cockwell P; Fraser D; Bowen T
Am J Pathol; 2018 Sep; 188(9):1982-1992. PubMed ID: 29981742
[TBL] [Abstract][Full Text] [Related]
17. MiR-30e-5p and MiR-15a-5p Expressions in Plasma and Urine of Type 1 Diabetic Patients With Diabetic Kidney Disease.
Dieter C; Assmann TS; Costa AR; Canani LH; de Souza BM; Bauer AC; Crispim D
Front Genet; 2019; 10():563. PubMed ID: 31249597
[TBL] [Abstract][Full Text] [Related]
18. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
19. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]